XML 32 R5.htm IDEA: XBRL DOCUMENT v2.3.0.15
Consolidated Cash Flow Statements (USD $)
In Thousands
9 Months Ended
Oct. 02, 2011
Oct. 03, 2010
Cash flows from operating activities:  
Net income (loss)$ 6,584$ (8,579)
Loss from discontinued operations(450)(496)
Income (loss) from continuing operations7,034(8,083)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:  
Depreciation and amortization10,79111,083
Stock-based compensation expense754776
Deferred revenue recognized(5,163)(4,584)
Deferred loan costs recognized153287
Write-off of debt issuance costs2770
Gain on sale of assets(4,189)(600)
Provision for excess and obsolete inventory564727
Other noncash items(2,186)669
Contributions to pension plans(753)(790)
Change in operating assets and liabilities:  
Accounts receivable(12,632)(8,819)
Inventory(6,346)(3,012)
Prepaid expenses and other assets1,138326
Accounts payable17,79310,134
Accrued and other liabilities1,9741,688
Net cash provided by (used in) operating activities9,209(198)
Cash flows from investing activities:  
Capital expenditures, net(3,827)(1,003)
Proceeds from sale of assets4,637721
Changes in nonoperating assets and liabilities447
Net cash provided by (used in) investing activities854(275)
Cash flows from financing activities:  
Repayment of former Revolving Credit Agreement(10,000)0
Repayment of former Senior Notes(13,305)0
Net proceeds from Credit Facility12,5000
Payments for deferred loan costs(387)0
Proceeds from the issuance of common stock640
Net cash used in financing activities(11,128)0
Net decrease in cash and cash equivalents(1,065)(473)
Cash and cash equivalents at beginning of period16,592[1]15,608
Cash and cash equivalents at end of period$ 15,527$ 15,135
[1]The balance sheet at December 31, 2010 has been derived from the audited consolidated financial statements at that date but does not include all information and footnotes required by accounting principles generally accepted in the United States for a complete set of financial statements.